Roxall Group

Company profile

Roxall Group company profile

Roxall Group develops and manufactures pharmaceutical products focused on allergy diagnosis and immunotherapy treatment. The company produces allergen extracts and related formulations designed for subcutaneous and sublingual administration, addressing respiratory and other IgE‑mediated allergies. Its portfolio includes diagnostic tests that help clinicians identify specific sensitizations and tailor personalized treatment plans. Roxall Group conducts in‑house research and development in immunology to improve dosing schemes, safety profiles and patient adherence. Clinical study participation supports the generation of data on efficacy, tolerability and long‑term outcomes. The organization collaborates with healthcare professionals and research institutions to advance protocols for allergy prevention, monitoring and therapeutic follow‑up.